Global Neglected Tropical Diseases Diagnosis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In March 2023, Kephera Diagnostics received a USD 3 million grant from the National Institutes of Health (NIH) to develop a point-of-care (POC) test for Chagas disease.

• In May 2023, Astellas Pharma Inc. announced commitment to support Global Health Innovative Technology Fund focusing on development of drugs, diagnostics, and vaccines to help combat various infectious diseases, including neglected tropical diseases.

The Global Neglected Tropical Diseases Diagnosis Market has undergone meticulous segmentation across multiple parameters to provide a comprehensive analysis of its dynamics. Segmentation by Disease includes various neglected tropical diseases such as malaria, dengue, chikungunya, Zika virus, schistosomiasis, lymphatic filariasis, and others, each presenting unique challenges and diagnostic requirements.

Diagnostic Method segmentation encompasses a wide range of techniques used for detecting and diagnosing neglected tropical diseases, including molecular diagnostics, serological testing, microscopy, rapid diagnostic tests (RDTs), and others. These methods vary in terms of sensitivity, specificity, and complexity, catering to different disease profiles and resource settings.

Service Type segmentation reflects the diverse range of diagnostic services offered, including laboratory-based testing, point-of-care diagnostics, and screening programs. End-Use segmentation covers various healthcare settings where neglected tropical disease diagnostics are utilized, including hospitals, clinics, diagnostic laboratories, research institutions, and community health centers.

By segmenting the market based on Disease, Diagnostic Method, Service Type, End-Use, and Geography, stakeholders gain valuable insights into the specific needs and preferences of different user groups and geographical regions. This comprehensive segmentation approach enables targeted strategies for product development, marketing, and distribution, facilitating the delivery of effective diagnostic solutions for neglected tropical diseases worldwide.

Global Neglected Tropical Diseases Diagnosis Segment Analysis

In this report, the Global Neglected Tropical Diseases Diagnosis Market has been segmented by Disease, Diagnostic Method, Service Type, End-Use and Geography.

Global Neglected Tropical Diseases Diagnosis Market, Segmentation by Disease

In this report, the Global Neglected Tropical Diseases Diagnosis Market has been segmented by Disease into Dengue, Chikungunya, Rabies, Leprosy, Buruli Ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematodiases, Echinococcosis, Chagas Disease (American Trypanosomiasis), Dracunculiasis, African Trypanosomiasis, Soil-transmitted Helminth Infections, Onchocerciasis, Schistosomiasis, Scabies and Other Ectoparasites, Snakebite Envenoming and Leishmaniasis.

The segmentation extends to diseases such as Chagas Disease (American Trypanosomiasis), Dracunculiasis, African Trypanosomiasis, and Soil-transmitted Helminth Infections, reflecting the broad scope of neglected tropical diseases covered in the market analysis. Other conditions like Onchocerciasis, Schistosomiasis, Scabies and Other Ectoparasites, Snakebite Envenoming, and Leishmaniasis are also included, underscoring the comprehensive nature of the segmentation approach.

By segmenting the market based on specific diseases, stakeholders gain valuable insights into the unique diagnostic needs and challenges associated with each condition. This comprehensive approach enables targeted strategies for research, development, and implementation of diagnostic tools and interventions tailored to the diverse array of neglected tropical diseases, ultimately contributing to improved healthcare outcomes and disease control efforts worldwide.

Global Neglected Tropical Diseases Diagnosis Market, Segmentation by Diagnostic Method

In this report, the Global Neglected Tropical Diseases Diagnosis Market has been segmented by Diagnostic Method into Conventional Method and Molecular/Modern Method.

The Conventional Method encompasses traditional diagnostic approaches such as microscopy, serological testing, and culture-based techniques, which have been widely used for diagnosing neglected tropical diseases (NTDs) over the years. These methods often rely on visual inspection or biochemical reactions to detect pathogens or their associated markers in patient samples.

In contrast, the Molecular/Modern Method segment includes advanced diagnostic techniques such as polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), and immunoassays, which offer enhanced sensitivity, specificity, and speed compared to conventional methods. These molecular and modern diagnostic tools enable the detection of NTDs at earlier stages of infection and provide more accurate results, facilitating timely treatment and disease control efforts.

By segmenting the market based on Diagnostic Method, stakeholders gain insights into the evolving landscape of NTD diagnostics, with a focus on both traditional and cutting-edge approaches. This segmentation approach enables healthcare providers, researchers, and policymakers to make informed decisions regarding the selection and implementation of diagnostic strategies tailored to the specific needs and challenges associated with neglected tropical diseases.

Global Neglected Tropical Diseases Diagnosis Market, Segmentation by Service Type

In this report, the Global Neglected Tropical Diseases Diagnosis Market has been segmented by Service Type into Centralized Service and POC Service.

Centralized services refer to diagnostic testing that is conducted in specialized laboratories or healthcare facilities equipped with advanced equipment and trained personnel. These centralized facilities often offer a wide range of diagnostic tests for neglected tropical diseases (NTDs) and provide accurate and reliable results.

On the other hand, POC services involve diagnostic testing that is performed at or near the site of patient care, often in resource-limited or remote settings. POC testing offers several advantages, including rapid results, which can facilitate timely treatment decisions and improve patient outcomes. POC tests are typically designed to be simple to use, requiring minimal training, and can be performed by healthcare providers with varying levels of expertise.

By segmenting the market based on Service Type, stakeholders gain insights into the different approaches to NTD diagnosis and the unique challenges associated with each. Centralized services are essential for comprehensive diagnostic testing and surveillance, while POC services play a crucial role in expanding access to timely and accurate diagnosis, particularly in underserved communities. The combination of both centralized and POC services is essential for addressing the complex diagnostic needs of NTDs and improving health outcomes for affected populations worldwide.

Global Neglected Tropical Diseases Diagnosis Market, Segmentation by End-Use

In this report, the Global Neglected Tropical Diseases Diagnosis Market has been segmented by End-Use into Clinical Labs, Hospitals /Clinics and Home Healthcare.

Clinical labs refer to specialized facilities equipped with advanced diagnostic equipment and staffed by trained laboratory professionals. These labs play a crucial role in conducting comprehensive diagnostic testing for neglected tropical diseases (NTDs), offering a wide range of tests and ensuring accurate and reliable results.

Hospitals and clinics represent another key end-use segment for NTD diagnosis, providing essential healthcare services to patients in both urban and rural areas. Hospitals and clinics often have dedicated diagnostic departments or laboratories where NTD testing can be performed alongside other medical investigations. This facilitates timely diagnosis and treatment of NTDs, contributing to improved patient outcomes.

Home healthcare settings are emerging as a significant end-use segment for NTD diagnosis, particularly for diseases that require long-term monitoring or self-testing. Home healthcare services enable patients to receive diagnostic testing and medical care in the comfort of their own homes, reducing the need for frequent hospital visits and improving patient convenience and satisfaction.

By segmenting the market based on End-Use, stakeholders gain valuable insights into the diverse settings where NTD diagnosis occurs and the specific needs and preferences of different user groups. This segmentation approach enables targeted strategies for product development, marketing, and distribution, ensuring that diagnostic solutions for NTDs are accessible and effective across various healthcare settings.

Global Neglected Tropical Diseases Diagnosis Market, Segmentation by Geography

In this report, the Global Neglected Tropical Diseases Diagnosis Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Neglected Tropical Diseases Diagnosis Market Share (%), by Geographical Region, 2024

North America and Europe are expected to hold significant market shares due to advanced healthcare infrastructure, robust research and development activities, and government initiatives to combat neglected tropical diseases (NTDs). These regions are likely to witness steady growth in diagnostic technologies and services, driven by increasing awareness and investments in public health programs.

The Asia Pacific region is anticipated to exhibit substantial growth potential in the neglected tropical diseases diagnosis market, attributed to the high prevalence of NTDs, growing healthcare expenditure, and initiatives by governments and international organizations to address these diseases. Additionally, rapid urbanization and improvements in healthcare infrastructure are expected to contribute to market expansion in this region.

The Middle East and Africa region are also projected to witness growth in the neglected tropical diseases diagnosis market, driven by rising healthcare investments, increasing awareness about NTDs, and efforts to strengthen healthcare systems. However, challenges such as limited access to healthcare services in remote areas and socioeconomic factors may hinder market growth to some extent.

Latin America is anticipated to register significant growth in the neglected tropical diseases diagnosis market, fueled by government initiatives, public health campaigns, and collaborations with international organizations to control and eliminate NTDs. The region's diverse geography and climate contribute to the prevalence of various neglected tropical diseases, necessitating effective diagnostic solutions and interventions.

By segmenting the market based on geography, stakeholders can gain insights into regional trends, challenges, and opportunities in the neglected tropical diseases diagnosis market. This facilitates strategic decision-making and targeted approaches to address the specific needs of different regions and enhance healthcare outcomes for affected populations worldwide.

This report provides an in depth analysis of various factors that impact the dynamics of Global Neglected Tropical Diseases Diagnosis Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers :

• Rising awareness and global initiatives
• Increased prevalence of NTDs

• Advancements in diagnostic technology - Advancements in diagnostic technology have significantly impacted the Global Neglected Tropical Diseases Diagnosis Market, revolutionizing the way these diseases are detected and managed. Molecular diagnostics, such as polymerase chain reaction (PCR) and nucleic acid amplification tests (NAATs), have emerged as powerful tools for the accurate and rapid detection of neglected tropical diseases (NTDs). These techniques allow for the direct detection of pathogen DNA or RNA in patient samples, offering higher sensitivity and specificity compared to traditional methods.

  Furthermore, point-of-care (POC) diagnostic devices have seen remarkable advancements, enabling rapid and decentralized testing in resource-limited settings. Portable POC devices, equipped with innovative technologies such as microfluidics and biosensors, facilitate on-site diagnosis and immediate treatment initiation, particularly in remote areas where access to centralized laboratories is limited. Additionally, the integration of digital health technologies, such as smartphone applications and cloud-based platforms, allows for real-time data analysis, remote monitoring, and decision support, further enhancing the efficiency and effectiveness of NTD diagnosis and management.

  These advancements in diagnostic technology not only improve the accuracy and speed of NTD diagnosis but also facilitate early detection, surveillance, and response efforts. By enabling timely and targeted interventions, these innovative diagnostic tools play a critical role in reducing the burden of NTDs and advancing global efforts towards their control and elimination.

Restraints :

• High costs of diagnostic tools
• Skilled workforce limitations

• Regulatory hurdles - The Global Neglected Tropical Diseases Diagnosis Market faces regulatory hurdles that can impact product development, approval, and market entry. Regulatory agencies around the world impose stringent requirements for diagnostic tests, ensuring safety, efficacy, and quality standards are met before products can be commercialized.

  One major challenge is obtaining regulatory approval for diagnostic tests, which often involves lengthy and complex processes. Regulatory submissions must demonstrate the analytical and clinical performance of the test, including sensitivity, specificity, and accuracy, through rigorous testing and validation studies. Meeting these requirements can be particularly challenging for novel diagnostic technologies or tests targeting rare or emerging neglected tropical diseases.

  Additionally, navigating the regulatory landscape across different regions and countries poses a significant hurdle for market players. Each regulatory jurisdiction may have its own set of requirements, timelines, and documentation standards, leading to fragmented and time-consuming approval processes. Harmonization efforts such as the International Medical Device Regulators Forum (IMDRF) aim to streamline regulatory requirements globally, but disparities still exist, particularly in resource-limited regions where NTDs are prevalent.

  Moreover, regulatory changes and updates can impact market dynamics, requiring companies to adapt their strategies and product portfolios accordingly. Changes in regulations related to diagnostic test approvals, reimbursement policies, or quality standards can affect market access, pricing, and competitiveness.

  Overall, navigating regulatory hurdles in the Global Neglected Tropical Diseases Diagnosis Market requires robust regulatory strategies, investment in compliance efforts, and collaboration with regulatory authorities to address challenges and ensure timely market access for innovative diagnostic solutions.

Opportunity :

• Focus on affordability

• Mobile health and point-of-care testing - The Global Neglected Tropical Diseases Diagnosis Market is witnessing a significant shift towards mobile health (mHealth) and point-of-care (POC) testing solutions. These innovative approaches are revolutionizing NTD diagnosis by bringing diagnostic testing closer to the patient, particularly in resource-limited or remote settings where access to centralized healthcare facilities may be limited.

  mHealth solutions leverage mobile technology, such as smartphones and tablets, to facilitate NTD diagnosis and management. Mobile apps enable healthcare providers to collect patient data, perform diagnostic tests, and transmit results securely, even in areas with limited infrastructure. This allows for real-time monitoring of NTD prevalence and transmission patterns, supporting more effective disease control strategies.

  Similarly, POC testing solutions enable rapid and accurate diagnosis of NTDs at the point of care, such as in community health centers, field clinics, or even in patients' homes. These compact and user-friendly diagnostic devices can detect NTDs within minutes, allowing for immediate treatment decisions and reducing the time to initiation of therapy. POC testing is particularly beneficial for diseases that require timely intervention, such as malaria, dengue, and lymphatic filariasis.

  The adoption of mHealth and POC testing solutions in the Global Neglected Tropical Diseases Diagnosis Market is driven by their potential to improve access to diagnostic services, enhance disease surveillance, and facilitate early detection and treatment of NTDs. As these technologies continue to evolve and become more accessible, they are expected to play a pivotal role in advancing NTD control efforts and improving health outcomes for affected populations worldwide.

Key players in Global Neglected Tropical Diseases Diagnosis Market include

• F. Hoffmann-La Roche Ltd
• Abbott
• Thermo Fisher Scientific, Inc
• ZeptoMetrix
• InBios International, Inc
• Genome Diagnostics Pvt. Ltd
• Omega Diagnostics Group PLC
• Coris Bioconcept SPRL
• DiaSys Diagnostic Systems GmbH
• Oscar Medicare Pvt Ltd

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis